Switch to:

Stemline Therapeutics Inc (STML) Ownership Data

Short Interest History (%)

This is the historical short interest of Stemline Therapeutics Inc, as measured by the Short Percentage Of Float.

Date Short Interest (%)Short Interest (Shares in Mil)
May 31, 20178.371.87
May 15, 20177.661.71
April 28, 20177.561.69
March 31, 20179.591.59
March 15, 20178.261.37
February 28, 20175.760.96
February 15, 20175.430.90
January 31, 20174.490.74
January 13, 20178.091.34
December 30, 20166.761.12
December 15, 20166.451.07
November 30, 20166.11.01
November 15, 20165.020.83
October 31, 20164.010.67
October 14, 20164.40.73
September 30, 20163.980.66
September 15, 20163.530.59
August 31, 20163.680.61
August 15, 20163.920.65
July 29, 20164.210.70
July 15, 20164.40.73
June 30, 20164.670.77
June 15, 20164.70.78
May 31, 20165.420.90
May 13, 20165.510.91
April 29, 20164.580.76
April 15, 20164.530.75
March 31, 20164.850.76
March 15, 20164.270.67
February 29, 20164.170.65
February 12, 20163.860.60
January 29, 20164.110.64
January 15, 20163.360.53
December 31, 20152.820.44
December 15, 20152.890.45
November 30, 20153.10.48
November 13, 20153.40.53
October 30, 20154.180.65
October 15, 20153.980.62
September 30, 20153.980.62
September 15, 20153.640.57
August 31, 20153.510.55
August 14, 20153.240.51
July 31, 201530.47
July 15, 20153.150.49
June 30, 20153.220.50
June 15, 20153.770.59
May 29, 20154.130.65
May 15, 20155.320.83
April 30, 20154.110.64
April 15, 20157.530.72
March 31, 20157.240.69
March 13, 20157.080.68
February 27, 20157.670.73
February 13, 20158.840.84
January 30, 20158.780.84
January 15, 20158.150.78
December 31, 20149.850.94
December 15, 201411.441.09
November 28, 201411.631.11
November 14, 201411.481.10
October 31, 201410.611.01
October 15, 201410.591.01
September 30, 20149.240.88
September 15, 20149.80.94
August 29, 20149.330.89
August 15, 20149.110.87
July 31, 20149.010.86
July 15, 20148.820.84
June 30, 20148.550.82
June 13, 20149.410.90
May 30, 20149.950.95
May 15, 20149.530.91
April 30, 20148.940.85
April 15, 201413.280.75
March 31, 201412.980.74
March 14, 201412.990.74
February 28, 201411.850.67
February 14, 201412.590.71
January 31, 20149.440.54
January 15, 20147.470.42
December 31, 20137.40.42
December 13, 20137.970.45
November 29, 20138.320.47
November 15, 20137.770.44
October 31, 20137.710.44
October 15, 20137.770.44
September 30, 20138.650.49
September 13, 201310.810.61
August 30, 201312.980.74
August 15, 201314.740.84
July 31, 201315.50.88
July 15, 201316.780.95
June 28, 20135.430.31
June 14, 20133.810.22
May 31, 20131.410.08
May 15, 20131.90.11
April 30, 20132.120.12
April 15, 20132.360.12
March 28, 20132.330.12
March 15, 20132.150.11
February 28, 20131.920.10
February 15, 20131.680.09
January 31, 20130.780.04

Institutional Ownership History (%)

This the Institutional Ownership History of Stemline Therapeutics IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership (%)Institutional Ownership (Shares in Mil)
March 31, 201752.1113.09
December 31, 201649.969.59
September 30, 201646.518.92
June 30, 201652.9710.11
March 31, 201654.1910.29
December 31, 201554.469.93
September 30, 201574.2911.13
June 30, 201563.5211.41
March 31, 201565.8611.79
December 31, 201460.698.06
September 30, 201454.927.29
June 30, 201464.918.47
March 31, 201465.198.63
December 31, 201364.718.47
September 30, 201360.187.76
June 30, 201366.278.31
March 31, 201338.953.49

Insider ownership (%)

This is the historical insider ownership of Stemline Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership (%)Insider Ownership (Shares in Mil)
May 31, 201711.852.97
April 30, 201711.872.97
March 31, 201712.572.97
February 28, 201710.792.55
January 31, 201713.382.56
December 31, 201613.382.56
November 30, 201613.382.56
October 31, 201613.412.56
September 30, 201613.412.56
August 31, 201613.412.56
July 31, 201613.462.56
June 30, 201613.462.56
May 31, 201613.462.56
April 30, 201613.492.56
March 31, 201614.052.56
February 29, 201614.282.57
January 31, 201612.432.24
December 31, 201513.492.56
November 30, 201513.332.40
October 31, 201513.422.41
September 30, 201513.422.41
August 31, 201513.472.41
July 31, 201513.472.41
June 30, 201513.472.41
May 31, 201513.222.37
April 30, 201513.282.37
March 31, 201513.12.33
February 28, 201516.642.21
January 31, 201516.692.22
December 31, 201416.282.16
November 30, 201416.722.22
October 31, 201416.842.23
September 30, 201416.842.23
August 31, 201416.842.23
July 31, 201416.792.22
June 30, 201416.792.22
May 31, 201416.792.22

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Ivan BergsteinCEO1,846,1287.35%2016-03-08
Mr. Kenneth HobermanCOO289,1901.15%2017-01-10
Dr. Eric K. Rowinsky,M.D.N/A143,6880.57%2015-04-27
Mr. David G. GioncoChief Accounting Officer103,3920.41%2017-01-19
Alan S. FormanN/A48,1400.19%2015-06-23
Stephen P. HallN/A40,0000.16%2013-06-19
Mr. J. Kevin BuchiN/A23,772less than 0.1%2015-06-23
Mr. Kenneth J. ZuerblisN/A21,963less than 0.1%2015-06-23
Eric L. DobmeierN/A17,963less than 0.1%2015-06-23
Ron BentsurN/A17,285less than 0.1%2015-06-23

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Candriam Luxembourg   Premium Plus244,0002016-12-311.270.062,611
Franklin Advisers Inc   Premium Plus1,449,0732016-12-317.560.0115,505
State Street Corp   Premium Plus251,8042016-12-311.31N/A2,694
Baker Bros Advisors LP   Premium Plus333,4972016-12-311.740.033,568
Eventide Asset Management, LLC   Premium Plus851,4002016-09-304.450.569,221
Vanguard Group Inc   Premium Plus620,9252016-12-313.24N/A6,644
BlackRock Fund Advisors   Premium Plus471,0552016-09-302.46N/A5,102
Fidelity Management and Research Company   Premium Plus1,861,3922016-09-309.72N/A20,159
Fidelity® Select Biotechnology Portfolio1,199,1692016-12-316.260.1512,831
Franklin Biotechnology Discovery Fund901,0692016-10-314.700.5010,272
Franklin Biotechnology Discovery Fund548,0042016-12-312.860.475,864
Driehaus Capital Management LLC501,4102017-01-312.121.945,114
Driehaus Event Driven Fund501,4102017-01-312.121.945,114
Eventide Gilead Fund441,4002016-09-302.300.344,780
Eventide Healthcare & Life Sciences Fund410,0002016-09-302.141.274,440
Vanguard Total Stock Mkt Idx377,1202017-01-311.59N/A3,847
iShares Russell 2000 (AU)330,2132017-02-230.880.012,130
Fidelity Advisor® Biotechnology Fund286,1342016-12-311.490.133,062
Candriam Eqs L Biotechnology244,0002016-12-311.270.482,611
Vanguard Extended Market Index Fund206,4312017-01-310.87N/A2,106

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK